Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Ramipril Patent Expiration

Ramipril is Used for reducing the risk of myocardial infarction, stroke, and death. It was first introduced by King Pharmaceuticals Llc in its drug Altace on Jan 28, 1991. 19 different companies have introduced drugs containing Ramipril.


Ramipril Patents

Given below is the list of patents protecting Ramipril, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Altace US7368469 Use of inhibitors of the renin-angiotensin system in the prevention of cardiovascular events Aug 30, 2020

(Expired)

 King Pfizer
Altace US7368469 Use of inhibitors of the renin-angiotensin system in the prevention of cardiovascular events Aug 30, 2020

(Expired)

 King Pharms Llc



Ramipril's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Ramipril Generic API Manufacturers

Several generic applications have been filed for Ramipril. The first generic version for Ramipril was by Watson Laboratories Inc and was approved on Oct 24, 2005. And the latest generic version is by Apotex Inc and was approved on Dec 2, 2015.

Given below is the list of companies who have filed for Ramipril generic, along with the locations of their manufacturing plants worldwide.


1. ACCORD HLTHCARE

Accord Healthcare Inc has filed for 4 different strengths of generic version for Ramipril. Given below are the details of the strengths of this generic introduced by Accord Hlthcare.

Strength Dosage Form Availability Application Pathway TE code Launch Date
2.5MG

capsule Discontinued ORAL N/A Apr 15, 2014
1.25MG

capsule Discontinued ORAL N/A Apr 15, 2014
10MG

capsule Discontinued ORAL N/A Apr 15, 2014
5MG

capsule Discontinued ORAL N/A Apr 15, 2014





2. ACTAVIS ELIZABETH

Actavis Elizabeth Llc has filed for 4 different strengths of generic version for Ramipril. Given below are the details of the strengths of this generic introduced by Actavis Elizabeth.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1.25MG

capsule Discontinued ORAL N/A Jun 18, 2008
2.5MG

capsule Discontinued ORAL N/A Jun 18, 2008
5MG

capsule Discontinued ORAL N/A Jun 18, 2008
10MG

capsule Discontinued ORAL N/A Jun 18, 2008


Manufacturing Plant Locations
New

Actavis Elizabeth's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Actavis Elizabeth as present at those locations.

Country City Firm Name
United States
Elizabeth Actavis Elizabeth LLC, A Company of Teva





3. APOTEX

Apotex Inc has filed for 4 different strengths of generic version for Ramipril. Given below are the details of the strengths of this generic introduced by Apotex.

Strength Dosage Form Availability Application Pathway TE code Launch Date
2.5MG

tablet Discontinued ORAL N/A Dec 2, 2015
5MG

tablet Discontinued ORAL N/A Dec 2, 2015
10MG

tablet Discontinued ORAL N/A Dec 2, 2015
1.25MG

tablet Discontinued ORAL N/A Dec 2, 2015


Manufacturing Plant Locations
New

Apotex's manufacturing plants are situated in 3 countries - United States, Canada, India. Given below are the details of these plant locations as well as the firm names of Apotex as present at those locations.

Country City Firm Name
United States
Weston Apotex Corp.
Canada
Brantford Apotex Pharmachem Inc.
Winnipeg Apotex Fermentation Inc.
North York Apotex Inc.
Richmond Hill Apotex Inc.
Toronto Apotex Inc.
Etobicoke Apotex, Inc.
India
Bangalore Apotex Research Private Limited - Bioequivalence Centre
Bengaluru Apotex Research Private Limited
Bangalore Apotex Pharmachem India Pvt Ltd.





4. AUROBINDO PHARMA LTD

Aurobindo Pharma Ltd has filed for 4 different strengths of generic version for Ramipril. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1.25MG

capsule Prescription ORAL AB Jun 8, 2011
5MG

capsule Prescription ORAL AB Jun 8, 2011
10MG

capsule Prescription ORAL AB Jun 8, 2011
2.5MG

capsule Prescription ORAL AB Jun 8, 2011


Manufacturing Plant Locations
New

Aurobindo Pharma Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma Ltd as present at those locations.

Country City Firm Name
India
Medchal Aurobindo Pharma Ltd





5. CHARTWELL MOLECULAR

Chartwell Molecular Holdings Llc has filed for 4 different strengths of generic version for Ramipril. Given below are the details of the strengths of this generic introduced by Chartwell Molecular.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1.25MG

capsule Prescription ORAL AB Jun 18, 2008
2.5MG

capsule Prescription ORAL AB Jun 18, 2008
5MG

capsule Prescription ORAL AB Jun 18, 2008
10MG

capsule Prescription ORAL AB Jun 18, 2008





6. CHARTWELL RX

Chartwell Rx Sciences Llc has filed for 4 different strengths of generic version for Ramipril. Given below are the details of the strengths of this generic introduced by Chartwell Rx.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1.25MG

capsule Discontinued ORAL N/A Jun 18, 2008
2.5MG

capsule Discontinued ORAL N/A Jun 18, 2008
5MG

capsule Discontinued ORAL N/A Jun 18, 2008
10MG

capsule Discontinued ORAL N/A Jun 18, 2008





7. CIPLA

Cipla Ltd has filed for 4 different strengths of generic version for Ramipril. Given below are the details of the strengths of this generic introduced by Cipla.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1.25MG

capsule Discontinued ORAL N/A Aug 7, 2008
10MG

capsule Discontinued ORAL N/A Aug 7, 2008
5MG

capsule Discontinued ORAL N/A Aug 7, 2008
2.5MG

capsule Discontinued ORAL N/A Aug 7, 2008


Manufacturing Plant Locations
New

Cipla's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Cipla as present at those locations.

Country City Firm Name
India
Mumbai Cipla Limited
Raigad Cipla Limited
Pithampur, District Dhar Cipla Limited
Bangalore Cipla Ltd.
Bengaluru Cipla Limited
Vasco Da Gama Cipla Limited
Kurkumbh Village, Dist. Pune Cipla, Ltd.





8. COREPHARMA

Corepharma Llc has filed for 4 different strengths of generic version for Ramipril. Given below are the details of the strengths of this generic introduced by Corepharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
10MG

capsule Prescription ORAL AB Jun 20, 2008
5MG

capsule Prescription ORAL AB Jun 20, 2008
2.5MG

capsule Prescription ORAL AB Jun 20, 2008
1.25MG

capsule Prescription ORAL AB Jun 20, 2008


Manufacturing Plant Locations
New

Corepharma's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Corepharma as present at those locations.

Country City Firm Name
United States
Middlesex CorePharma, LLC





9. HIKMA

Hikma Pharmaceuticals Usa Inc has filed for 4 different strengths of generic version for Ramipril. Given below are the details of the strengths of this generic introduced by Hikma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1.25MG

capsule Prescription ORAL AB Jun 18, 2008
2.5MG

capsule Prescription ORAL AB Jun 18, 2008
5MG

capsule Prescription ORAL AB Jun 18, 2008
10MG

capsule Prescription ORAL AB Jun 18, 2008


Manufacturing Plant Locations
New

Hikma's manufacturing plants are situated in 3 countries - United States, Portugal, Jordan. Given below are the details of these plant locations as well as the firm names of Hikma as present at those locations.

Country City Firm Name
United States
Eatontown Hikma Pharmaceuticals USA, Inc.
Carlsbad Hikma Cali Inc. DBA Leucadia Pharmaceuticals
Cherry Hill Hikma Pharmaceuticals USA Inc.
Dayton Hikma Injectables USA Inc
Portugal
Terrugem Snt Hikma Farmaceutica, (Portugal) S.A.
Jordan
Amman Hikma Pharmaceuticals LLC





10. LUPIN

Lupin Ltd has filed for 4 different strengths of generic version for Ramipril. Given below are the details of the strengths of this generic introduced by Lupin.

Strength Dosage Form Availability Application Pathway TE code Launch Date
10MG

capsule Prescription ORAL AB Jun 9, 2008
5MG

capsule Prescription ORAL AB Jun 9, 2008
2.5MG

capsule Prescription ORAL AB Jun 9, 2008
1.25MG

capsule Prescription ORAL AB Jun 9, 2008


Manufacturing Plant Locations
New

Lupin's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Lupin as present at those locations.

Country City Firm Name
India
Nagpur Lupin Limited
Mandideep Lupin Limited
Pithampur Lupin Limited (Unit 1)
Pirangut Lupin Limited
Mandideep Lupin Limited (Unit II)
Pithampur Lupin Limited
Anakapalli District Lupin Manufacturing Solutions Limited
Aurangabad Lupin Ltd.
Tarapur, Thane Lupin Limited
Vasco Da Gama Lupin Limited
Navi Mumbai LUPIN LIMITED
Pune Lupin Bioresearch Center
Dabhasa LUPIN MANUFACTURING SOLUTIONS LIMITED
Mumbai Lupin Limited
United States
Coral Springs Lupin Research Inc
Baltimore Lupin Pharmaceuticals Inc.





11. NATCO PHARMA

Natco Pharma Ltd has filed for 4 different strengths of generic version for Ramipril. Given below are the details of the strengths of this generic introduced by Natco Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
10MG

tablet Discontinued ORAL N/A Jun 30, 2011
1.25MG

tablet Discontinued ORAL N/A Jun 30, 2011
2.5MG

tablet Discontinued ORAL N/A Jun 30, 2011
5MG

tablet Discontinued ORAL N/A Jun 30, 2011


Manufacturing Plant Locations
New

Natco Pharma's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Natco Pharma as present at those locations.

Country City Firm Name
India
Hyderabad Natco Pharma Limited
Rangareddy District Natco Pharma Ltd. - Chemical Division
Chennai NATCO Pharma Limited Chemical Division Chennai
Rangareddy NATCO Pharma Limited
Paravada Natco Pharma Limited
Hyderabad NATCO PHARMA LTD





12. RANBAXY LABS LTD

Ranbaxy Laboratories Ltd has filed for 2 different strengths of generic version for Ramipril. Given below are the details of the strengths of this generic introduced by Ranbaxy Labs Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
5MG

capsule Discontinued ORAL N/A Mar 6, 2009
10MG

capsule Discontinued ORAL N/A Mar 6, 2009





13. SENORES PHARMS

Senores Pharmaceuticals Inc has filed for 4 different strengths of generic version for Ramipril. Given below are the details of the strengths of this generic introduced by Senores Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
2.5MG

capsule Prescription ORAL AB Jun 18, 2008
1.25MG

capsule Prescription ORAL AB Jun 18, 2008
5MG

capsule Prescription ORAL AB Jun 18, 2008
10MG

capsule Prescription ORAL AB Jun 18, 2008





14. TEVA PHARMS

Teva Pharmaceuticals Usa has filed for 4 different strengths of generic version for Ramipril. Given below are the details of the strengths of this generic introduced by Teva Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1.25MG

capsule Discontinued ORAL N/A Jun 18, 2008
2.5MG

capsule Discontinued ORAL N/A Jun 18, 2008
5MG

capsule Discontinued ORAL N/A Jun 18, 2008
10MG

capsule Discontinued ORAL N/A Jun 18, 2008





15. WATSON LABS

Watson Laboratories Inc has filed for 4 different strengths of generic version for Ramipril. Given below are the details of the strengths of this generic introduced by Watson Labs.

Strength Dosage Form Availability Application Pathway TE code Launch Date
2.5MG

capsule Prescription ORAL AB Oct 24, 2005
1.25MG

capsule Prescription ORAL AB Oct 24, 2005
5MG

capsule Discontinued ORAL N/A Oct 24, 2005
10MG

capsule Prescription ORAL AB Oct 24, 2005





16. ZYDUS PHARMS USA

Zydus Pharmaceuticals Usa Inc has filed for 4 different strengths of generic version for Ramipril. Given below are the details of the strengths of this generic introduced by Zydus Pharms Usa.

Strength Dosage Form Availability Application Pathway TE code Launch Date
10MG

capsule Prescription ORAL AB Sep 2, 2008
5MG

capsule Prescription ORAL AB Sep 2, 2008
2.5MG

capsule Prescription ORAL AB Sep 2, 2008
1.25MG

capsule Prescription ORAL AB Sep 2, 2008





17. ZYDUS PHARMS USA INC

Zydus Pharmaceuticals Usa Inc has filed for 4 different strengths of generic version for Ramipril. Given below are the details of the strengths of this generic introduced by Zydus Pharms Usa Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
10MG

tablet Discontinued ORAL N/A Sep 24, 2009
1.25MG

tablet Discontinued ORAL N/A Sep 24, 2009
2.5MG

tablet Discontinued ORAL N/A Sep 24, 2009
5MG

tablet Discontinued ORAL N/A Sep 24, 2009